Article Versions Notes

Kulikowska de Nałęcz A, Ciszak L, Usnarska-Zubkiewicz L, Frydecka I, Pawlak E, Szmyrka M, Kosmaczewska A. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients. International Journal of Molecular Sciences. 2021; 22(17):9298. https://doi.org/10.3390/ijms22179298

Kulikowska de Nałęcz, Anna, Lidia Ciszak, Lidia Usnarska-Zubkiewicz, Irena Frydecka, Edyta Pawlak, Magdalena Szmyrka, and Agata Kosmaczewska. 2021. "Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients" International Journal of Molecular Sciences 22, no. 17: 9298. https://doi.org/10.3390/ijms22179298

Kulikowska de Nałęcz, A., Ciszak, L., Usnarska-Zubkiewicz, L., Frydecka, I., Pawlak, E., Szmyrka, M., & Kosmaczewska, A. (2021). Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients. International Journal of Molecular Sciences, 22(17), 9298. https://doi.org/10.3390/ijms22179298